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Abstract
Background: In Australia and in the United Kingdom (UK) access to specialists is sanctioned by
General Practitioners (GPs). It is important to understand how practitioners determine which
patients warrant referral.
Methods:  A self-administered structured vignette postal survey of General Practitioners in
Western Australia and the United Kingdom. Sixty-four vignettes describing patients with colorectal
symptoms were constructed encompassing six clinical details. Nine vignettes, chosen at random,
were presented to each individual. Respondents were asked if they would refer the patient to a
specialist and how urgently. Logistic regression and parametric tests were used to analyse the data
Results: We received 260 completed questionnaires. 58% of 'cancer vignettes' were selected for
'urgent' referral. 1632/2367 or 69% of all vignettes were selected for referral. After adjusting for
clustering the model suggests that 38.4% of the variability is explained by all the clinical variables as
well as the age and experience of the respondents. 1012 or 42.8 % of vignettes were referred
'urgently'. After adjusting for clustering the data suggests that 31.3 % of the variability is explained
by the model. The age of the respondents, the location of the practice and all the clinical variables
were significant in the decision to refer urgently.
Conclusion: GPs' referral decisions for patients with lower bowel symptoms are similar in the
two countries. We question the wisdom of streaming referrals from primary care without a strong
evidence base and an effective intervention for implementing guidelines. We conclude that
implementation must take into account the profile of patients but also the characteristics of GPs
and referral policies.
Background
In Australia, as in the United Kingdom (UK), patients can
only access specialists after referral by a General Practi-
tioner (GP) but notwithstanding these similarities there
are marked differences in health care organisation. In Aus-
tralia, there are two health care systems:
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▪ A clearly defined public hospital system manages the
health care needs of the entire population. Access to hos-
pital specialists follows referral from GPs;
▪ A private hospital system manages patients with private
health insurance, currently estimated to cover 44% of the
population [1]. Access is also via referral by GPs however
appointments in most cases are usually offered much
more speedily than in the publicly funded hospital sector.
In Britain there are also two health care systems:
• A universally available and 'free at the point of use'
National Health Service. Paid for by general taxation and
used by the overwhelming majority of the population;
￿ A small private health care sector with only 11% of the
population covered by health insurance [2].
Where cancer enters a GP's differential diagnosis, rapid
access to specialists in the England is guaranteed for
patients with signs and symptoms outlined in govern-
ment guidelines [3]. In Australia no such arrangements
exist and the scheduling of appointments to a publicly
funded hospital is governed by local specialists based on
the clinical details relayed in a referral letter. Whatever the
context, it is generally acknowledged that there are sub-
stantial gaps between the best evidence and the manage-
ment patients receive from doctors [4].
Colorectal cancer is an important public health problem
globally with nearly one million new cases diagnosed
world-wide each year and half a million deaths [5]. The
best known symptoms of this cancer, namely persistent
diarrhoea and episodes of rectal bleeding, are also com-
mon although the vast majority of people who experience
such symptoms do not have cancer. In most cases a diag-
nostic colonoscopy is indicated to rule out malignancy
rather than to confirm the clinical impression of cancer.
However in recent years researchers suggest that it may be
possible to identify those who are at higher risk of cancer
from their symptom profile. Most colorectal cancers are
diagnosed in patients over 65 years of age, in other words
older than those currently eligible for government funded
colorectal screening in Australia or the UK. Therefore the
majority of cases will be diagnosed after medical consul-
tation with symptoms rather than picked up at screening
while asymptomatic. Few symptomatic people with lower
bowel symptoms in Australia or Britain consult a medical
practitioner and very few of these are referred for further
investigation and definitive diagnosis to a specialist [6].
Of those symptomatic people who consult a GP, most can
be managed without specialist advice but others are over-
looked who would benefit [7,8].
It has been suggested that there is a wide variation in the
way Australian GPs manage colorectal symptoms and by
corollary, this may disadvantage some patients [9]. Data
from the UK also suggest that cancer referral guidelines do
not appear to have changed referral practice in Britain or
outcomes for cancer patients [10]. In this structured
vignette survey of GPs we aim to explore the impact of a
variety of clinical and respondent characteristics on GPs'
decision to refer patients with lower bowel symptoms.
Methods
Ethics
Ethics approval was granted in Australia by the ethics
committee of the University of Western Australia (Ref: RA/
4/1/1462) and in the UK by the North Sheffield LREC (NS
2004 2 1861). Return of the completed questionnaire was
considered consent to participate in the survey.
A self-administered postal survey was carried out. Self-
administered questionnaires have the advantage of deal-
ing better with sensitive issues where anonymity is
assured. Vignettes also capture something approximating
a real-life situation and allow some degree of contextuali-
zation when considering the issues [11]. The value of this
approach is also that we removed the confounding effect
of doctor-patient miscommunication. Vignettes or 'sto-
ries' about patients with colorectal symptoms were con-
structed to include six clinical details with two possible
variations. Therefore there were 64 potential scenarios to
cover each of the possible combinations [12]. The
vignettes were presented to the sample in an 'incomplete-
within-blocks' design to reduce the number of vignettes
presented to each respondent to nine.
Scenarios for 'cancer' patients were based on features of
colorectal cancer as incorporated in UK national clinical
guidelines and reflect guidance to Australian GPs [13,14].
Respondents were told that the patient in question did
not have private health insurance in order to explore dif-
ferences in decision making focusing on clinical rather
than organisational issues. This implied the patient would
have to be referred to a 'public' hospital where in both
countries the patient would incur no charges and the
appointment would be subject to the clinical need. Each
respondent was potentially presented with two cases in
which the evidence recommends an urgent referral:
1. Unexplained iron deficiency anaemia
2. Patient aged greater then 60 years of age with rectal
bleeding and or altered bowel habit of at least 6 weeks
duration. Although the UK guidelines stress the impor-
tance of looser or more frequent bowel motions as the sig-
nificant change in bowel habit there has been doubt castBMC Family Practice 2008, 9:2 http://www.biomedcentral.com/1471-2296/9/2
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that persistent constipation is not a presenting symptom
of cancer [15].
Thirty-eight out of the 64 vignettes contained at least one
such scenario, henceforth referred to as 'cancer' vignettes.
The other vignettes described cases that the guidelines
imply do not constitute high risk cancer patients.
The questionnaire was piloted and refined following feed-
back from clinician volunteers. Each scenario was pre-
sented as a letter from a GP to a hospital specialist and
styled in the manner displayed in the examples shown in
Figure 1. Six clinical variables with two possible variations
were included:
1. Age of patient (35 years or older than 60 years)
2. Duration of symptoms (6 weeks or two weeks)
3. Rectal bleeding (present or absent)
4. Change in bowel habit (present or absent)
5. Weight loss (present or absent)
6. Iron deficiency anaemia. (present or absent)
Each scenario contained similar information but was
worded differently in order to introduce freshness to each
case.
The respondents were asked whether they would refer the
patient described in each scenario, how soon they would
seek investigation and if they thought the patient may be
harbouring a malignancy as shown in Figure 2.
Demographic data about each respondent collected
included:
1. Age
2. Sex
3. Number of patients seen per week.
4. Single-handed/group
5. Number of years in clinical practice
6. Teaching status
7. Geographical location (Metro, outer metro and rural).
Outer metropolitan areas are urban centres with popula-
tions of around 100,000 people. Rural areas are those
serving populations of less than 25,000 [16].
In order to model up to 13 explanatory variables for one
outcome variable we required 154 respondents [17]. We
anticipated a 50–60% response rate. Logistic regression
was used to examine the relative importance of specific
signs, symptoms and risk factors that may influence the
decision to refer via the urgent or 'other' pathway. In order
to control for clustering, a cluster option was used to esti-
mate robust standard errors. All analysis was performed
on Stata V9 [18].
Recruitment
GPs were recruited at random from the list of practitioners
registered at the Royal Australian College of General Prac-
titioners (RACGP) in Western Australia and in the UK
from GPs listed in metropolitan areas of North Trent. In
Australia recruitment was also designed to include a sig-
nificant number of rural practitioners. Questionnaires
were disseminated by post with a covering letter. Where
necessary a reminder questionnaire was sent six weeks
after the first mailing. Anonymity was protected, as practi-
tioner identities were coded with only administrative staff
able to identify individuals.
Results
Five hundred questionnaires were distributed, two-hun-
dred and sixty completed responses were received, a
response rate of fifty-two percent. The genders of the
Questions posed after each vignette Figure 2
Questions posed after each vignette.
Dear Endoscopist, 
 
I would value your opinion about this 70 year old patient who has been feeling unwell. 
The patient spoke of a six week history which includes rectal bleeding, a change in bowel 
habit, no weight loss and a normal full blood count. There is no relevant family history 
and I could find no abnormalities on examination. The patient has no other history and 
does not have private medical insurance. 
 
--------------------------------------------------------------------------------------------------------- 
 
I thought I should refer this 35 year old patient who has been feeling unwell. The patient 
presents with a two week history of altered bowel habit, no rectal bleeding, no weight loss 
and iron deficiency anaemia. There is no relevant family history and there are no physical 
findings on examination. The patient has no other history and does not have private 
medical insurance. 
Examples of vignettes Figure 1
Examples of vignettes.
x At this stage would you refer this patient?         Yes          No              Not sure   
                                           
x Preferred pathway:           Urgent ( within 2 weeks)       Other (not urgent)    
x Probability of cancer (circle which you think is the most appropriate):     
                    5                     4                     3                        2                 1  
              very likely             likely            unsure         unlikely            very unlikely  
x Underline any information in this letter that suggests that the patient might have a malignancy. (e.g. six week history) or 
there are no such words, phrases or information (please tick the box)   
x Comments (if any): BMC Family Practice 2008, 9:2 http://www.biomedcentral.com/1471-2296/9/2
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respondents were equally distributed with the majority of
practitioners older than 40 years of age. In Australia
approximately one third of respondents were rural practi-
tioners, which corresponds to the known distribution of
practitioners in that country [19]. Most practitioners had
been in practice more than five years and the majority
were in group practice and were teaching practices. The
demographic details of the respondents are shown in
Table 1. The 'correct' decision to refer patients on the
'appropriate' pathway (i.e. 'urgent' referral for those with
cancer symptoms and routine referral for all other cases)
was made in 56.2% of cases overall. 'Cancer vignettes'
were presented 1433 times in the survey. On three hun-
dred and fifty occasions (25%) cases were explicitly recog-
nised as 'likely' or 'very likely' to have cancer but 775
(58%) were referred 'urgently'.
Vignettes selected for referral
1632 or 69% of the vignettes were selected for referral. The
outcome variable: 'refer now' was set as the independent
variable and modelled with six respondent variables as
explanatory variables including: location of practice
(rural, metro and outer metro), site of practice (UK vs.
WA), respondent age and gender, number of years in prac-
tice and teaching status along with the clinical variables in
the vignettes namely age of patient described in vignette,
gender, rectal bleeding, change in bowel habit, iron defi-
ciency anaemia and weight loss. After adjusting for clus-
tering the model suggests that 38.4% of the variability is
explained by the independent variables. The model has a
sensitivity of 94.12% and a specificity of 41.78%. The pos-
itive predictive value is 78.89% and negative predictive
value of 75.45%. Table 2 displays only those variables
which significantly contributed to the model. Area under
the ROC curve was 0.89 (95% CI: 0.87, 0.91). Practicing
in Australia as opposed to the UK was not found to be rel-
evant. All six clinical variables and the age of the respond-
ent and length of clinical experience were significant.
Vignettes referred 'urgently'
1012 or 42.8 % of vignettes were referred 'urgently', of
these 911 vignettes (90%) merited an 'urgent' referral
based on the criteria mentioned above. The outcome var-
iable: 'refer urgently' was set as the independent variable
and modelled with six respondent variables as explana-
tory variables including; location of practice (rural, metro
and outer metro), site of practice (UK vs. WA), respondent
age and gender, number of years in practice and teaching
status along with the clinical variables in the vignettes
namely age of patient described in vignette, gender, rec-
tal bleeding, change in bowel habit, iron deficiency
anaemia, weight loss and cancer vignette as defined by
clinical guidelines. After adjusting for clustering, the data
suggests that 31.3 % of the variability is explained by these
variables. The model has a sensitivity of 81.7% and a spe-
cificity of 65.6%. The positive predictive value is 68.6%
Table 2: Impact of variables on decision to refer symptomatic 
patient
Variable OR Robust S.E. P>|z| 95% C.I.
Respondent 
variables
Respondent age
30–39 5.3 2.72 0.001 1.9 to 14.5
40–49 3.2 1.74 0.03 1.1 to 9.3
Years in practice (20+) 3 1.24 0.007 1.3 to 6.8
Vignette variables
Age in vignette (> 60 
years)
2.95 0.46 <0.001 2.2 to 4.0
Duration of symptoms 
(6 weeks)
2.3 0.38 <0.001 1.7 to 3.2
Rectal bleeding 11.76 2.99 <0.001 7.1 to 19.4
Altered bowel habit 4.94 0.84 <0.001 3.5 to 6.9
Iron Deficiency anaemia 7.12 1.28 <0.001 5.0 to 10.2
Weight loss 2.62 0.46 <0.001 1.9 to 3.7
Table 1: Demography of respondents to survey
SITE
Variable UK WA Total
GP Gender
Males 46 (51.7) 87 (50.9) 133 (51.1)
GP Age Group
20–29 0 10 (5.8) 10
30–39 21 (23.6) 59 (34.5) 80
40–49 35 (39.3) 55 (32.2) 90
50–59 25 (28.1) 30 (17.5) 55
60+ 7 (7.9) 17 (9.9) 24
Practice Location
Rural 0 52 52
Metro 89 79 168
Outer Metro 0 41 41
Number of years in practice
<5 8 40 48
5–10 17 29 46
10–15 16 32 48
15–20 16 25 41
20+ 31 45 76
Full time equivalent GPs in the 
practice
<=1 15 21 36
2–4 45 82 127
5–7 27 54 81
>=8 2 11 13
Teaching
None 28 49 77
Medical students 17 51 68
GP Registrars 12 12 24
Other 7 6 13
Combinations 25 51 76BMC Family Practice 2008, 9:2 http://www.biomedcentral.com/1471-2296/9/2
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and negative predictive value is 79.6%. Table 3 displays
the extent to which variables significantly contributed to
the model. Area under the ROC curve was 0.86 (95% CI:
0.83, 0.87). 'Cancer vignettes' were twice as likely to be
selected for urgent referral as others. All the clinical varia-
bles listed in bold above were significant and only the age
of the respondent and practicing in outer metro locations
were significant.
Discussion
The differences in health care organisation were not
reflected in a difference in GP decisions about which
patients to refer when focused on publicly funded services
in these countries. Assuming that a colonoscopy is war-
ranted for unexplained iron deficiency anaemia or for per-
sistent symptoms in an older patient, just over half the
cases presented in this study would be referred on the 'cor-
rect' pathway and a slightly greater proportion of 'cancer
vignettes' selected for 'urgent' referral. However only a
quarter of these, were explicitly recognised as warranting
an urgent referral because of a higher risk of 'cancer', not-
ing that 38 out of the 64 were intended to be 'cancer
vignettes', indicating uncertainty when diagnosing cancer
in a population where the condition presents infre-
quently. Interviews with GPs about managing lower
bowel symptoms suggest that the mode of presentation
and the disclosure of embarrassing symptoms had a sig-
nificant influence on the decisions made at consultation
[20]. By presenting clinicians explicitly with clinical
details we were able to record decisions not influenced by
miscommunication. Surprisingly and despite any possible
respondent bias, the data are consistent with practice
recorded in a review of actual referrals in the locality
where this study was conducted in the UK [21]. Ideally we
would have liked to validate clinician responses to this
survey with observations from their clinical practice but
this was not possible within the resources at our disposal.
A reasonable degree of variability was explained by the
clinical and respondent variables modelled. The symptom
of weight loss exerted considerable influence on the deci-
sion to refer patients urgently. Weight loss is a common
feature of many cancers and is often a harbinger of poor
prognosis [22]. Therefore practitioners may be selecting
patients for urgent investigation when the disease is
already at a relatively advanced stage. There is some evi-
dence that colorectal cancer patients referred from general
practice to public hospitals in Western Australia enter spe-
cialist services with advanced disease [23]. Evidence from
the UK also suggests guidelines have made little difference
to the prognosis of colorectal cancer patients in that coun-
try where they are promoted to stream patients for urgent
specialist appointments [24]. The impact of 'morbidity'
has previously been demonstrated as misleading practi-
tioners at the point of referral. Mitchell and colleagues
concluded that referrals to specialists were sometimes
based on measures that did not correspond with serious
pathology [25]. More recent evidence in studies of color-
ectal cancer suggests that weight loss is not a marker of
advanced disease [26]. However, in the context of upper
gastrointestinal cancer weight loss is accepted as indicat-
ing poor survival. Therefore patients with so-called 'alarm
symptoms' and incurable pathology may be selected for
urgent endoscopy while those lesser morbidity but treata-
ble pathology channelled to routine waiting lists [27].
Therefore weight loss is not a sensible reason for referral if
early diagnosis of cancer is the goal. That is not to say that
patients with marked weight loss do not warrant an early
specialist appointment, but weight loss, on current evi-
dence is not a helpful basis on which to refer patients for
timely treatment of gastrointestinal cancers.
The influence of patients' characteristics on referral deci-
sions has been widely reported and echo much of the data
reported here. In their study of differences in referral rates
in the UK Sullivan et al conclude that 'morbidity' is likely
to explain some of the variability but much of the varia-
bility remains 'unexplained' [28]. However a study of
Canadian family practitioners also explored practitioner
characteristics and similarly posit that the age and practice
location of the referring doctor exert an appreciable
impact on referral patterns even within Canada's universal
health insurance system [29]. In our data relating to Aus-
tralian practice these factors were also of interest although
with small numbers and no other explanatory data we can
only speculate on the reasons.
Table 3: Impact of variables on decision to refer patients 
urgently
Variable OR Robust S.E. P>|z| 95% C.I.
Respondent variables
Outer metro location 2.2 0.76 0.01 1.2 to 4.4
30–39 2.8 0.87 0.001 1.5 to 5.2
40–49 2.3 0.91 0.03 1.1 to 5.0
50–59 4.6 2.12 0.001 1.9 to 11.4
60+ 15.4 9.84 <0.001 4.4 to 53.8
Vignette variables
Age in vignette 
(> 60 years)
2.9 0.4 <0.001 2.4 to 4.4
Duration of symptoms 
(6 weeks)
2.1 0.28 <0.001 1.6 to 2.7
Rectal bleeding 4.4 0.73 <0.001 3.2 to 6.1
Altered bowel habit 3.5 0.51 <0.001 2.8 to 4.8
Iron Deficiency anaemia 2.1 0.50 <0.001 2.5 to 4.5
Weight loss 4.1 0.61 <0.001 2.9 to 5.3
'Cancer vignette' 2.0 0.5 0.01 1.2 to 3.40BMC Family Practice 2008, 9:2 http://www.biomedcentral.com/1471-2296/9/2
Page 6 of 7
(page number not for citation purposes)
To politicians, health care managers and the general pub-
lic guidelines promote evidence based practice, protect
patient safety, ensure equity of access and or contain costs.
However compliance with existing referral 'guidelines' is a
contentious issue. In respect to colorectal cancer, recent
research calls into question the value of 'early' referral of
patients with 'symptomatic' colorectal cancer. 'Delay' for
patients with the recognised 'red flag' symptoms meas-
ured in months or up to a year may not inevitably result
in a poorer prognosis [30]. The issue of 'red flag' symp-
toms was also challenged in a systematic review that con-
cluded that clinical features currently listed in guidelines
have unacceptably low predictive value [24]. Focusing on
practitioner decision making Gabbay and May suggested
that doctors do not act on published evidence base but on
the anecdotes and unsubstantiated opinions of respected
colleagues or personal experience [31]. Our data support
the notion that the application of guidelines is moder-
ated, or even negated, by the characteristics of those for
whom they are intended. This is important because, in
Britain, GPs are involved in prioritising health care
expenditure in a so-called 'primary care led' National
Health Service and serve as both poacher and game keeper
[32].
Conclusion
In this structured vignette study selection of patients with
colorectal symptoms reflects the data from surveys of
actual referrals and does not indicate consistently evi-
dence based practice. However despite these similarities
in referral behaviour the observed outcomes for colorectal
cancer are moderately better in Australia than they are in
the UK [33]. We speculate as others have done that this
may be because GPs have greater access to urgent colonos-
copy in Australia, perhaps via the private health care sec-
tor [23]. We conclude that practitioners should have
access to rapid appointments for those patients whose
symptoms are worrisome either because of morbidity or
because the patient may benefit from curative therapy.
This calls into question the wisdom of streaming referrals
from primary care without effective interventions for the
implementation of evidence based guidelines.
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